HYALGAN® Injection Video

shoe image

HYALGAN® injection video

View the introduction to the Hyalgan Injection Video below for a brief summary about osteoarthritis of the knee, HYALGAN® safety & efficacy, and administering HYALGAN® in your practice.

You also may download the entire injection video for a complete tutorial of HYALGAN® injections. The entire Injection video is approximately 45 minutes in length

It looks like you do not have an updated Flash Plug-in. To view the current page, please download it.


Download it for later viewing
View at Medscape Web site

Link to download a printable version of the Injection Tutorial TranscriptTranscript

To download the materials, you will need Adobe Reader. Download the Free Adobe Reader now.

Link to Adobe Reader download page

If you would like to order a DVD of the injection tutorial for your office, please contact your Sales Representative or call 1-800-223-1062 to request a Sales Representative visit.

Important Safety Information for HYALGAN®

  • HYALGAN® is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative nonpha-rmacologic therapy, and to simple analgesics, eg, acetaminophen
  • HYALGAN® is contraindicated in patients with known hypersensitivity to hyaluronate preparations. Intra-articular injections are contraindicated in cases of past and present infections or skin diseases in the area of the injection site
  • The effectiveness of a single treatment cycle of less than 3 injections has not been established
  • In the US clinical trial of 495 patients, the only adverse event showing statistical significance vs placebo was injection-site pain
  • Other adverse events included gastrointestinal complaints, headache, local ecchymosis and rash, local joint pain and swelling, and local pruritus. However, the incidence of these events was similar in the HYALGAN®-treated and placebo groups
  • In other clinical studies, the frequency and severity of adverse events occurring during repeat treatment cycles did not increase over that reported for a single treatment cycle

Click here for additional important information for HYALGAN®.